Profile data is unavailable for this security.
About the company
Ortin Global Limited, formerly Ortin Laboratories Limited, is engaged in manufacturing and trading of pharmaceuticals, drugs, and intermediates. It manufactures a range of pharmaceutical formulations of tablets, capsules, syrups, and dry powders. Its products include Acefinac, ACEFINAC-CZ, ACEFINAC-P, ACEFINAC-SP, ACTAZID, ACTY-P, ALERFEX-120, ALERFEX-180, ALERGID, ALERGID- L, AMLOBID, CARBAMOL, CARISNIL, CALDY-C AZITIN-500, DOCEF-200, GLYCITROL, GLYCITROL-M, LORACT, MEBOL, NEUROCOB, FERUP, IRFER Z, MINVITA-B, NILCID, ORICILLIN-DX, PEG POWDER, PEG-D POWDER, ALKASIT, COF-XL, and others. Its formulations include Anti Diabetics, Anti Allergics, Anti Anginal and Cardiovascular, Analgesics and Antipyretics, and Anti Biotics-Quinolones. Its active pharmaceutical ingredient (API) intermediates include Anti retro viral, Grignard, Diborane, Ciprofloxacin and Tramadol. It is also manufacturing for different importers to market their products in Russia, Ukraine, Kajakistan and South America.
- Revenue in INR (TTM)7.49m
- Net income in INR-81.60m
- Incorporated1986
- Employees--
- LocationOrtin Global LtdFlat No: 502, Palem Towers, BarkatpuraHYDERABAD 500044IndiaIND
- Phone+91 4 027562055
- Fax+91 4 027562055
- Websitehttp://www.ortinlabsindia.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Parenteral Drugs (India) Ltd | 84.96m | -763.62m | 86.47m | -- | -- | -- | -- | 1.02 | -25.61 | -25.61 | 2.85 | -276.37 | 0.0162 | 4.17 | 0.9266 | -- | -14.52 | -17.82 | -- | -- | 35.67 | 40.22 | -898.77 | -191.93 | 0.055 | -0.5192 | -- | -- | -30.17 | -48.70 | 37.26 | -- | -- | -- |
Ortin Global Ltd | 7.49m | -81.60m | 171.98m | -- | -- | -- | -- | 22.96 | -10.04 | -10.04 | 0.9277 | -- | -- | -- | -- | -- | -- | -3.46 | -- | -8.85 | -315.55 | 23.25 | -1,089.22 | -3.67 | -- | -19.02 | -- | -- | -64.93 | -58.32 | -8,490.81 | -- | -- | -- |
Saroja Pharma Industries India Ltd | -100.00bn | -100.00bn | 238.21m | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -9.78 | -- | -6.97 | -- | -- | -- |
Vilin Bio Med Ltd | -100.00bn | -100.00bn | 251.80m | -- | -- | 2.90 | -- | -- | -- | -- | -- | 6.22 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.9741 | -- | 0.4159 | -- | -4.27 | -- | -72.38 | -- | -- | -- |